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Abstract The aims of this study were to develop a
biological large diameter vascular graft by decellular-
isation of native human aorta to remove the immuno-
genic cells whilst retaining the essential
biomechanical, and biochemical properties for the
ultimate benefit of patients with infected synthetic
grafts. Donor aortas (n = 6) were subjected to an
adaptation of a propriety decellularisation process to
remove the cells and acellularity assessed by histo-
logical analysis and extraction and quantification of
total DNA. The biocompatibility of the acellular
aortas was determined using standard contact cyto-
toxicity tests. Collagen and denatured collagen content
of aortas was determined and immunohistochemistry
was used to determine the presence of specific
extracellular matrix proteins. Donor aortas (n = 6)
were divided into two, with one half subject to
decellularisation and the other half retained as native
tissue. The native and decellularised aorta sections
were then subject to uniaxial tensile testing to failure
[axial and circumferential directions] and suture
retention testing. The data was compared using a
paired t-test. Histological evaluation showed an
absence of cells in the treated aortas and retention of
histoarchitecture including elastin content. The decel-
lularised aortas had less than 15 ng mg-1 total DNA
per dry weight (mean 94% reduction) and were
biocompatible as determined by in vitro contact
cytotoxicity tests. There were no gross changes in
the histoarchitecture [elastin and collagen matrix] of
the acellular aortas compared to native controls. The
decellularisation process also reduced calcium depos-
its within the tissue. The uniaxial tensile and suture
retention testing revealed no significant differences in
the material properties (p[ 0.05) of decellularised
aorta. The decellularisation procedure resulted in
minimal changes to the biological and biomechanical
properties of the donor aortas. Acellular donor aorta
has excellent potential for use as a large diameter
vascular graft.
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Introduction
Large diameter vascular grafts have been used
successfully to treat a number of conditions, including
aortic aneurysms and aortic dissections. Abdominal
aortic aneurysms affect 4–7% of men and 1–2% of
women over the age of 65 years (Robinson et al.
2013). Aortic dissection is the most serious compli-
cation of thoracic aortic disease and has been shown to
affect from 6 to 16.3 in 100,000 cases per year
(Howard et al. 2013; Olsson et al. 2006).
Currently, the preferred treatment option for aortic
replacement is to insert a readily available synthetic
graft, most commonly a woven Dacron or expanded
polytetrafluoroethylene; ePTFE graft. Aortic replace-
ment with Dacron prostheses is performed widely
with acceptable outcomes and has a relatively low rate
of post-implantation and graft related complications.
Infection rates of synthetic grafts in open surgery can,
however be as high as 6% (Cernohorsky et al. 2011;
Heyer et al. 2009; Vicaretti et al. 1998) and although
the incidence of infection in endovascular aortic repair
(EVAR) surgery is scarce (\ 1%) the recommended
treatment for infected synthetic grafts remains the
same; an open surgical procedure involving wide
debridement of the infected vessel and the surrounding
tissue, followed by extra-anatomic revascularisation
with long term antibiotics (Swain et al. 2004; Ting
et al. 2005; Davila et al. 2015).
In the setting of an infected synthetic aortic graft, a
cryopreserved human allograft provides an alternative
method of reconstruction for patients. Historically,
allografts were prone to disintegration, aneurysmal
degeneration and rupture post-operatively and this
limited their use in early cases of arterial reconstruc-
tion following infection (Szilagyi et al. 1970). The use
of cryopreserved heart valves in aortic arch and
cardiac valve reconstruction (O’Brien et al. 2001;
Sabik et al. 2002) however rekindled the exploration
of other vascular locations that may be suitable for
cryopreserved vascular allografts.
The use of vascular allografts may however lead to
allosensitization (Benedetto et al. 2001;Wilshaw et al.
2012). Aortic allograft conduits (and heart valves)
have been shown to undergo degenerative changes,
including calcification, following implantation. Cal-
cification and degeneration is believed to be caused by
the immune response towards donor cells (Baskett
et al. 2003; Dignan et al. 2003; Muratov et al. 2010;
Webb et al. 1992), and can result in the failure of the
graft. Moreover, vascular allografts may exhibit
inherent calcification. This is due to the dystrophic
calcification that occurs in vascular tissue due to
aging, atherosclerosis and aortic stenosis. Calcifica-
tion of the aortic wall occurs as a part of the aging
process in the majority of people. Vascular allografts
will therefore likely exhibit calcification to some
degree, and this will be detrimental to the function and
performance of the graft since calcium deposits may
act as foci for additional calcification.
Since cryopreserved allografts contain donor cells
with associated antigens which initiate an adverse host
response and act as foci for calcification it is logical to
propose that removal of the cellular components of
allografts would reduce the immune response and
calcification. The aim of decellularisation of allograft
tissue is to remove immunogenic cells, creating
biocompatible grafts without significantly affecting
the structural components of the extracellular matrix
and biomechanical properties. This approach has been
successfully used to produce decellularised heart
valve allografts which have been used clinically
(Bechtel et al. 2005; Brown et al. 2010; Burch et al.
2010; Cebotari et al. 2011; Ruzmetov et al. 2012;
Tavakkol et al. 2005; Zehr et al. 2005). There are,
however, no studies that have investigated the inherent
calcification present in donor cardiovascular tissues
before and after decellularisation.
We hypothesize that decellularisation, together
with removal of calcium, from aortic allografts will
improve life-span and durability when compared to
current cryopreserved aortic allografts. Here we
describe the application of a proprietary decellulari-
sation process (Wilshaw et al. 2012), based on the use
of low concentration sodium dodecyl sulphate (SDS)
to aortic allografts. In order to reduce the inherent
calcium content of the donor aortas, an initial decal-
cification treatment using ethylenediaminetetraacetic
acid (EDTA) was incorporated into the process.
Decellularisation of aortic allograft is an attractive
approach since retention of the histo-architecture of
the native aorta may allow constructive remodelling
by host cells to generate a living, functional graft.
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Materials and methods
Tissue procurement
Human aortas were obtained from UKNHS Blood and
Transplant Tissue and Eye Services. The study was
carried out under full UK NHS ethical approval (08/
H0405/65). The aortas were obtained within 48 h of
death. The tissues were stored and transported at
- 80 C. The aortas were of thoracic origin, between
8 and 20 cm in length and varied in internal diameter
from 1.5 to 3.0 cm. Excess fat and connective tissue
were removed and the adventitial surface of the aortas
was scraped using a scalpel blade prior to washing in
phosphate-buffered saline (PBS; Oxoid). The tissue
used in this study was provided frommale donors aged
between 45 and 79.
Decellularisation
The decellularisation process was modified from
Wilshaw et al. (2012) for human donor common
femoral arteries. The decellularisation process was
carried out using aseptic technique throughout. The
aortas were thawed at 40 C for 60 min and only
aortas with no grossly visible atherosclerotic plaques
or calcification were used. Aortas were subsequently
washed twice in a 10% (w/v) ethylenediaminete-
traacetic acid (EDTA; VWR International) solution
with 10 KIU mL-1 Aprotinin (Mayfair House) in
water for 24 h at 40–45 C. The aortas were then
sequentially washed in hypotonic Tris buffer (10 mM
Tris; Sigma-Aldrich, 0.1%; v/v; EDTA, and
10 KIU mL-1 Aprotinin, pH 8.0) at 40–45 C for
24 h; 0.1% (v/v) sodium dodecyl sulphate (SDS;
Sigma-Aldrich) in Tris hypotonic buffer at 40–45 C
for 24 h; PBS twice for 15 min at 42 C before a 72 h
wash at 40–45 C in PBS. The tissues were treated
with nuclease (50 mM tris, 1 mM MgCl26H20,
10 U mL-1 Benzonase (Merck)) for 3 h twice before
subsequent washes in PBS twice for 15 min at 42 C
followed by a 24 h wash at 40–45 C. Aortas were
decontaminated in Cambridge antibiotic solution
(Source Bioscience) for 3 h at 37 C followed by
washes in PBS twice for 15 min at 42 C followed by
a 24 h wash at 40–45 C. The aortas were washed
using hypertonic buffer solution (1.5 M sodium chlo-
ride (ThermoFisher Scientific Ltd.) and 50 mM Tris,
pH 7.5) for 24 h at 40–45 C. Final washes in PBS
included two washes for 15 min at 42 C followed by
a 24 h wash at 40–45 C and a final 72 h at 40–45 C.
This resulted in a 14 day decellularisation process.
Histological evaluation
Native and decellularised tissue samples from each of
six different human aortas were fixed in zinc fixative
solution (0.5% w/v zinc chloride (VWR Chemicals),
0.5% w/v zinc acetate (VWR Chemicals), in 0.1 M
Tris buffer containing 0.05% w/v calcium acetate
(Sigma) at pH 7.4) for 48 h, dehydrated, and embed-
ded in paraffin wax using a Leica Tissue Processor
(TP1020). Serial sections (6–8 lm) were stained with
haematoxylin and eosin (H&E), picrosirius red/Mill-
ers elastin (to visualize collagen and elastin) and
alcian blue (glycosaminoglycans, GAGs) using stan-
dard histological methods. Cell nuclei were visualised
using DAPI dye (Sigma Aldrich); briefly, sections of
tissue were rehydrated in a graded alcohol series
before they were incubated in the dark in 0.1 lg mL-1
DAPI dye in dye buffer (10 mM Tris, 1 mM EDTA,
1 mM sodium chloride in water) for 10 min. The
sections were viewed using an upright Zeiss Imager
M2 microscope under normal Kohler illumination or
under fluorescent illumination using a DAPI filter
(kex = 340–380 nm/kem = 435–485 nm) and images
were captured digitally using Zen Blue Pro (Zeiss).
Calcium detection and quantification
Sections of native and decellularised zinc fixed tissue
were subject to von Kossa staining. Briefly, sections of
tissue were rehydrated in a graded alcohol series
before staining in a 1% w/v silver nitrate (AnalarR)
solution in water for 1 h on a Kenro Light
Box (2 9 15 W bulbs). Following this the samples
were washed in a 158 mM sodium thiosulphate
pentahydrate (VWR) solution in water for 5 min
before rinsing in water and counterstaining with eosin
for 30 s. Calcium quantification was performed using
a commercial kit (Abcam; AB102505). Samples of
tissue for calcium quantification were lyophilised to a
constant weight using a Modulo D freeze dryer
(Thermo) before being hydrolysed in 6 M hydrochlo-
ric acid for 6 h at 120 C, at 15 lb sqin-1 and
subsequent neutralization with 6 M sodium hydrox-
ide. The samples were then assayed according to the
manufacturer’s recommendations. Calcium content
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was quantified by interpolation of the absorption of the
sample data from a known set of calcium standards
(Abcam; AB102505).
DNA extraction and quantification
Total DNA was extracted from human native and
decellularised tissues (n = 6) using a DNeasy blood
and tissue kit from Qiagen. Finely macerated tissue
(* 25 to 50 mg wet weight native tissue or * 100 to
150 mg wet weight decellularised tissue) was lyophi-
lised to a constant weight, and the freeze dried tissue
digested using proteinase K at 56 C for 16 h. RNAse
was used to remove any RNA present within the
samples. The samples were washed by centrifugation
to remove contaminating matter. Finally, the DNA
was eluted into Eppendorf tubes and quantified using a
NanoDrop spectrophotometer at 260 nm (Thermo
Fisher Scientific).
In-vitro biocompatibility assays
Cell culture
A549 adenocarcinomic human alveolar basal epithe-
lial cells (ECACC) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10%
(v/v) FBS, 100 U mL-1 penicillin, 100 mg mL-1
streptomycin, and 100 mM L-glutamine (Lonza) at
37 C in 5% CO2 (v/v) in air. BHK baby hamster
kidney cells (ECACC) were cultured in Glasgow’s
modified Eagle’s medium (GMEM) containing 5% (v/
v) FBS, 10% (v/v) tryptose phosphate broth (Oxoid) at
37 C in 100 U mL-1 penicillin, 100 mg mL-1 strep-
tomycin, and 100 mM L-glutamine at 37 C in 5%
CO2 (v/v) in air.
Contact cytotoxicity assay
Samples of decellularised human aorta (5 mm2;
n = 6) were attached to the centre of the wells of a
six-well culture plate using steri-strips (Medisave).
Cyanoacrylate glue was used as positive control, and
steri strips alone were used as the negative control.
A549 or BHK cells were seeded into each well at a
density that allowed 80% confluence after cell seed-
ing. Plates were incubated at 37 C in 5% (v/v) CO2 in
air for 48 h. The cells were fixed with 10% (v/v)
neutral buffered formalin (Genta Medica) for 10 min
prior to staining with Giemsa solution (VWR Interna-
tional) for 5 min. The culture wells were carefully
rinsed with distilled water until the water ran clear and
air dried before examining cell morphology and
distribution under normal Kohler illumination.
Immunohistochemistry
Native and decellularised zinc fixed and paraffin
embedded tissue sections (from n = 6 human aortas)
were stained with monoclonal antibodies against
collagen I (Millipore; IgG isotype, polyclonal, 1:500
dilution), collagen III (Millipore; IgG1 isotype, clone
IE7-D7, 1:100 dilution), collagen IV (Dako; IgG1
isotype, clone PHM-12, 1:200 dilution), von Wille-
brand factor (Dako; IgG isotype, polyclonal, 1:400
dilution), fibronectin (Vector; IgG1 isotype, clone
568, 1:150 dilution) and laminin (Sigma; IgG1
isotype, clone LAM-89, 1:1000 dilution). Immunola-
beling was carried out using an Ultravision detection
system (Thermo Scientific). Antigen retrieval was
employed using proteinase K (Dako; room tempera-
ture for 20 min—collagen III, von Willebrand factor,
fibronectin and laminin), proteinase K followed by
trypsin digestion (0.05% w/v trypsin 0.52 mM
EDTA.4Na in HBSS with phenol red (Sigma) for
30 s) (collagen IV) and Vector antigen unmasking
solution citric based (collagen I). Hydrogen peroxide
(Sigma) was used to block endogenous peroxidase
activity. Isotype control antibodies (IgG and IgG1;
Dako; used at the same concentrations as the test
antibody) and omission of the primary antibody served
as negative controls. Sections were viewed using
Kohler and all images were captured digitally using
Zen Blue Pro (Zeiss).
Biomechanical testing
Paired samples of native and decellularised aorta were
generated by halving native aorta before the decellu-
larisation process, with half undergoing decellularisa-
tion and the remaining native aorta utilised in the
biomechanical assays detailed below (uniaxial tensile
testing and suture pull-out testing).
Uniaxial tensile testing
Paired native (n = 6) and decellularised (n = 6)
human aorta tissue samples were subjected to low
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strain rate uniaxial loading to failure. Native and
decellularised human aorta were cut open along their
length and rectangular aortic tissue strips with width
5 mm were cut in both axial and circumferential
orientations from each native and decellularised
human aorta. The tissue was cut using a custom-made
cutter comprising of two Stanley knife blades held a
fixed 5 mm apart. Prior to testing, the thickness of the
samples was measured at six points along the gauge
length using a digital thickness gauge (PK-0510,
Mitutoyo UK Ltd) with a resolution of 0.01 mm, and
their average thickness was calculated. Subsequently,
the samples were mounted onto a custommade holder.
The holder was supported by a removable bracket that
allowed alignment of the two holder grips, pre-
defining the gauge length of the specimen at 10 mm,
and ensuring that no load was imposed onto the
specimen until the test began. Once the test sample
was clamped onto the holder, the holder with
supporting bracket was secured to an Instron 3365
(Instron Corporation) uniaxial tensile tester with
50 N load cell and the supporting bracket was
removed. The samples were tested at 10 mm min-1
under hydrated conditions in PBS at 37 C. The load
and extension data was recorded during tests. The
load-extension data were converted into stress–strain
data from which the ultimate tensile stress (UTS),
elastin phase slope and collagen phase slope were
determined.
Suture pull-out testing: Samples of native (n = 6)
and decellularised (n = 6) aorta were dissected into
rectangular specimens of 20 mm length and 15 mm
width. A 4-0 non-absorbable monofilament suture
(Premilene) was placed into the free end of the tissue,
4 mm from the end to form a loop. Prior to testing, the
thickness of the samples was measured near the suture
hole using a thickness gauge (as above). Subsequently,
the samples were mounted in an Instron 3365
(Instron Corporation) uniaxial tensile tester with a
50 N load cell. The tissue was clamped using one set
of the grips, the other set of grips were used to clamp
the looped suture. A uniaxial load was applied to the
suture until it was pulled out of the specimen, with
strain rate 10 mm min-1. The maximum force (N) re-
quired to pull-out the suture was recorded.
Determination of collagen and denatured collagen
content
Hydroxyproline (as an indirect measure of collagen)
assays were performed on samples of lyophilised
native and decellularised human aortas (n = 6).
Hydroxyproline assay
Samples were hydrolysed in 6 M hydrochloric acid for
6 h at 120 C, at 15 lb sqin-1 and subsequently
neutralized with 6 M sodium hydroxide. The hydrox-
yproline assay was performed as described by
Edwards and O’Brien (1980). The hydroxyproline
content was determined by interpolation of sample
data from a trans-4-hydroxy-L-proline standard curve.
The total collagen content was calculated by using a
hydroxyproline to collagen ratio of 1:7.14 (Harding
and Wesley 1968).
Denatured collagen assay
The assay was performed as described by Bank et al.
(1997). Samples were treated with 5 mg mL-1 a-
chymotrypsin (Sigma) in 0.1 M tris buffer at pH 7.8
containing 2.5 mM calcium chloride for 24 h at
30 C. The samples were centrifuged at 6009g for
10 min. The supernatant was hydrolysed, and then
neutralized and the hydroxyproline content was
determined as described above.
Statistical analysis
All numerical data were analysed using Graphpad
Prism 6 and all data were presented as mean ± 95%
confidence intervals (CI). The Student’s t-test and
paired samples t-test was used for comparison of two
group means as appropriate.
Results
Development of the decellularisation process
for human donor aortas
When the original (Wilshaw et al. 2012) decellular-
isation process was applied to the human aortas,
cellular remnants were frequently observed in H&E
and DAPI stained sections of the tunica media
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(Fig. 1a, b). Since sections of the native human aortas
showed the presence of calcium deposits when stained
with von Kossa (Fig. 1c, d), it was hypothesized that
incomplete decellularisation was due to calcification
present in the donor aortas. The original decellulari-
sation protocol failed to remove this calcium, and
calcium deposits initially observed in the tunica media
appeared to be washed into the intima and remaining
adventitia during the decellularisation process
(Fig. 1e). A decalcification step was therefore intro-
duced to the start of the decellularisation process. von
Kossa staining of aorta tissue sections from samples
that had been decalcified and decellularised
demonstrated greatly reduced calcium staining
(Fig. 1f). Quantitation of the calcium content of human
aortas before and after decalcification and decellular-
isation showed that native human aorta contained
0.63 ± 0.39 (95% CI) lg mg-1 calcium, which was
reduced to 0.07 ± 0.06 lg mg-1 following the decal-
cification and decellularisation process (Fig. 1g).
Histological evaluation of native
and decellularised aortas
The decalcification and decellularisation process was
applied to a further six human donor aortas. There was
Fig. 1 Sections of human aorta stained using haematoxylin and
eosin (a) and DAPI (b). Sections stained using DAPI were
viewed using fluorescence microscopy, the cell nuclei appeared
blue (kex 365 nm/kem 445 nm) and the ECM green (kex 470 nm/
kem 525 nm), black/white arrows denotes remaining cell nuclei
following decellularisation. c, d Sections of native human aorta
stained using Von Kossa’s stain. e Sections of decellularised
human aorta, processed using initial decellularisation protocol,
stained using Von Kossa’s stain, black arrows highlight regions
of calcification. f Von Kossa staining of decellularised human
aorta decellularised using the revised protocol. Images were
viewed and acquired using normal Kohler illumination and
a 9 20 objective, scale bars represent 100 lm. g quantification
of the calcium content of fresh and acellular human aorta, data
represents mean (n = 6) ± 95% confidence intervals. *Signif-
icantly different as determined using two tailed, unpaired
Students t-test, p\ 0.005
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no evidence of gross changes to the histioarchitecture
of the aorta tissues following the process (Fig. 2a, b)
and observations of H&E stained sections showed no
evidence of cell nuclei or whole cells in the decellu-
larised tissues. Sections of the native aorta stained
with H&E showed the trilaminar structure; comprised
of the intima, tunica media and the tunica adventitia
(Fig. 2a, b). The majority of the adventitia had been
removed by blunt dissection prior to decellularisation
(Fig. 2b). Although these layers were visible in the
sections stained using the range of histological stain-
ing methods, they were most obvious when the
sections were stained with Sirius red and Miller’s
elastin (Fig. 2c–f). Miller’s elastin and Sirius red
Fig. 2 Sections of (a, c, e, g, i) native and (b, d, f, h, j) acellular
human aorta stained using (a, b) Haematoxylin and eosin (c,
d) Millers elastin (e, f) Sirius red (g, h) Alcian blue and (i,
j) DAPI. Sections stained using DAPI were viewed using
fluorescence microscopy, the cell nuclei appeared blue (kex
365 nm/kem 445 nm) and the ECM green (kex 470 nm/kem
525 nm). Images were acquired using a 9 20 objective, scale
bars represent 100 lm
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predominantly stain collagen and elastin fibrils that are
circumferentially orientated in native vessels (Fig. 2c,
e) and these fibres and their orientation were retained
following decellularisation (Fig. 2d, f). Alcian blue
stained sections revealed the GAG content of both
native and decellularised tissues, with no apparent loss
of GAG staining following the decellularisation
process (Fig. 2g, h). GAG staining was most intense
around the endothelium. DAPI stained sections of
decellularised aorta tissue sections demonstrated a
lack of visible cell nuclei when compared to native
control tissue sections (Fig. 2i, j).
DNA content of native and decellularised aortas
The DNA was extracted from native and decellu-
larised human aortas (n = 6) using a commercially
available kit and quantified spectrophotometrically
(260 nm). The DNA content of native aorta was
88 ± 43.4 (95% CI) ng mg-1 and acellular was
5 ± 1.5 ng mg-1 by dry weight. This represented a
94% reduction in DNA content between native and
decellularised aorta.
In-vitro biocompatibility of decellularised aortas
Microscopic analysis of the contact cytotoxicity assay
plates demonstrated that A549 and BHK cells grew up
to and in contact with samples of decellularised human
aorta (Fig. 3). No zones of cell lysis or changes in cell
morphology were apparent (Fig. 3). Steri-strip (neg-
ative control) was biocompatible and cyanoacrylate
contact adhesive (positive control) caused cell lysis
(Fig. 3).
Immunohistochemical analysis of native
and decellularised aorta
Immunohistochemical staining of sections of decellu-
larised human aorta demonstrated no loss of collagen
type I and III when compared to sections of native
tissue (Fig. 4a–d). Collagen type IV labelling was
observed throughout the intima and tunica media, in
both native and decellularised aortas, but was not
present in the adventitia (Fig. 4e, f). Von Willebrand
factor labelling was located in the endothelium and
positive labelling was observed in both native and
decellularised aorta (Fig. 4g, h). Fibronectin was
labelled throughout sections of the tissues with no
visible reduction in decellularised aorta compared to
native aorta (Fig. 4i, j). Laminin was present through-
out sections of the native and decellularised tissues,
although there was a slight reduction of laminin
labelling towards the luminal aspect of the tunica
intima in decellularised tissue sections compared to
native tissue sections (Fig. 4k, l).
Biomechanical properties of native
and decellularised aortas
The uniaxial tensile testing indicated no significant
changes in the material properties of decellularised
aorta tissue when compared to paired samples of
native aorta. No significant differences were observed
in collagen and elastin phase slopes and the ultimate
tensile stress in either the circumferential or axial
directions (paired samples t-test, p[ 0.05; Table 1).
All failures occurred at or near to the centre of the
gauge length.
During the suture pull-out testing, a suture was
pulled out of the samples (native and decellularised)
and the samples ruptured in the circumferential
direction perpendicular to the direction of the testing.
No significant differences were observed between the
maximum suture pull-out force (N) required to pull out
the sutures between native and decellularised aorta
(paired samples t-test, p[ 0.05; Table 1).
Collagen and denatured collagen content of native
and decellularised aortas
The collagen content of native and decellularised
aortas was 173.6 ± 29.4 (95% CI) and
292.6 ± 206.4 mg mL-1 respectively. The values
were not significantly different (Student’s t-test,
p = 0.18, Fig. 5a). There was no significant differ-
ence in the levels of denatured collagen of native and
decellularised aortas (Student’s t-test, p = 0.26). The
denatured collagen content of native and decellu-
larised aorta was 14.8 ± 6.6 (95% CI) and
24.0 ± 15.33 mg mL-1 respectively (Fig. 5b).
Discussion
There is a clinical need for a biological graft for the
replacement of infected synthetic grafts used in the
treatment of aortic dissection and aortic aneurism.
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Studies have shown that decellularisation signifi-
cantly reduces both the cellular and humoral immune
response to allograft tissue (Dahl et al. 2011; Hilbert
et al. 2004; Hopkins et al. 2009; Meyer et al. 2005).
Clinically, the early and midterm results obtained with
decellularised aortic valve allografts have shown good
structural integrity, a low rate of calcification and no
structural or morphological alteration (da Costa et al.
2010). Decellularised aortic valves present a promis-
ing alternative for aortic valve replacement in selected
patients. For aortic grafts, cryopreserved aortas have
been used in the clinic with reports of good long-term
survival and patency (Gomez-Caro et al. 2008; Noel
et al. 2002), but the presence of remaining donor
cells/material in cryopreserved allografts may how-
ever lead to allosensitization (Benedetto et al. 2001;
Wilshaw et al. 2012).
The aims of this study were to test the hypothesis
that it was possible to decellularise human donor aorta
tissues without adversely affecting the biomechanical
or biological properties of the tissue. The decellu-
larised aortas would then have the potential to be
deployed in surgeries to replace infected synthetic
aortic grafts, or indeed in primary aortic repair
procedures without risk of an adverse host immune
response.
The initial decellularisation process for human
donor aortas was based on a protocol developed for
allogeneic femoral arteries (Wilshaw et al. 2012). This
process utilises hypotonic buffer in combination with
low concentration SDS and nuclease enzymes to
remove native cells whilst preserving the extracellular
matrix. The use of detergents and osmotic shock is a
common approach utilised to decellularise soft tissues
(Crapo et al. 2011; Hogg et al. 2013; Luo et al. 2014;
Wilshaw et al. 2012). Antibiotics were used to reduce
the initial bioburden of the aortas as part of the
decellularisation process. The initial decellularisation
process, however resulted in acellular tissues with a
significant calcium content. It was apparent that the
donor aortas invariably exhibited calcification to some
extent. This was most likely due to the dystrophic
calcification that occurs in vascular tissue as a
common complication in aging, atherosclerosis and
aortic stenosis. When human aortic tissue ages the
calcium content increases (Elliott and McGrath 1994;
Tohno et al. 1998). The tissue used in this study was
provided from donors aged between 45 and 79 and
Fig. 3 Contact cytotoxicity assessment of acellular human
aorta, samples were cultured with human A549 lung epithelial
cells. a negative control (steri-strip only), b positive control
(cyanoacrylate) and c acellular human aorta. Additionally baby
hamster kidney cells were used, d negative control (steri-strip
only), e positive control (cyanoacrylate) and f acellular human
aorta. The cell sheets were stained using Giemsa’s stain and all
images acquired using a 9 2 objective, the scale bars represent
500 lm
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Fig. 4 Sections of (a, c, e, g, i, k) native and (b, d, f, h, j,
l) acellular human aorta labelled using monoclonal antibodies
against (a, b) Collagen type I (c, d) Collagen type III (e,
f) Collagen type IV (g, h) Von Willebrand factor, (i,
j) Fibronectin and (k, l) Laminin. Images were acquired using
Kohler illumination and a 9 10 objective, scale bars represent
200 lm
Table 1 Biomechanical parameters of native and decellularised human aorta
Sample (orientation) Collagen phase slope
(MPa)
Elastin phase slope
(MPa)
Ultimate tensile stress
(MPa)
Suture pull-out force
(N)
Native (axial) 2.34 ± 0.95 0.31 ± 0.20 1.08 ± 0.35 6.09 ± 1.11
Decellularised (axial) 2.27 ± 1.52 0.50 ± 0.60 0.91 ± 0.47 6.98 ± 2.81
Native (circumferential) 3.14 ± 1.58 0.24 ± 0.17 1.43 ± 1.02
Decellularised
(circumferential)
3.86 ± 1.75 0.28 ± 0.17 1.33 ± 0.44
Low strain rate loading to failure of decellularised and native aorta tissue in the circumferential and axial directions [data represents
mean (n = 6) ± 95% confidence intervals, paired samples t-test, p[ 0.05]. A suture was pulled out of samples of native and
decellularised aortas to determine the maximum force (N) required to pull out the sutures [data represents mean (n = 6) ± 95%
confidence intervals, paired samples t-test, p[ 0.05]
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therefore exhibited significant calcification upon
receipt.
The incorporation of a decalcification step using
10% (w/v) EDTA prior to decellularisation of the
donor aortas enabled the production of tissues devoid
of cells with no overt changes to the histo-architecture
and circa 90% reduction in the calcium content. The
residual calcium levels (70 mg mg-1 or 70 ppm) were
in the region of those reported for decellularised
6-month old porcine aorta (91 ppm; Paniagua Gutier-
rez et al. 2015). Interestingly, alcian blue staining of
tissue sections demonstrated no visible loss of GAGs.
This was in contrast to other published studies that
have noted a loss of GAG staining in various tissues
decellularised using SDS (Luo et al. 2014; Stapleton
et al. 2008; Xu et al. 2014).
The DNA content of the decellularised biological
scaffolds is widely considered to be important in
determining whether a decellularisation procedure is
successful (Lotze et al. 2007; Nagata et al. 2010).
Previous studies have shown that there is residual
DNA present in existing commercially available
biological scaffolds (Gilbert et al. 2009). Gilbert and
colleagues used PicogreenTM assay to quantify double
stranded DNA remaining following decellularisation.
However the present study quantified total DNA using
absorbance at 260 nm. The Picogreen assay is a more
sensitive assay and can detect lower levels of DNA,
but it is limited to detecting double stranded DNA.
Utilising spectrophotometry to measure the absor-
bance of DNA in solution, both single stranded (and
therefore partially digested DNA) as well as double
stranded DNA was detected, allowing for true quan-
tification of DNA content remaining in decellularised
aorta. Following decellularisation there was an
average of 5 ng mg-1 (dry weight) of DNA remain-
ing, representing extremely low levels.
Collagen IV and laminin staining was present
throughout the decellularised aorta, although laminin
staining was reduced in the luminal regions, whereas
staining with von Willebrand factor was localised to
the luminal surface (basement membrane). The pres-
ence of von Willebrand staining in the basement
membrane in the decellularised vessel demonstrated
retention of at least one basement membrane protein
VonWillebrand factor has been shown to be present in
the extracellular matrix filaments and co-distributes
with other components such as fibronectin and colla-
gen IV (Handin and Wagner 1989; Wagner 1990).
Laminin plays a role in the development of blood
vessels. It has been suggested that reduction in laminin
causes reduced innervation in implanted blood vessels
in in vivo studies (Gavazzi et al. 1995; Hallmann et al.
2005), however additional in vivo implantation studies
would be required to see if this would be the case with
the decellularised aorta.
The decellularised aorta was biocompatible to cells
in in vitro tests with no significant loss of collagen
content or increase in denatured collagen. There was a
trend to increased levels of collagen and denatured
collagen in decellularised aortas compared to native
aortas (not significant) which was most likely due to
the change in tissue mass caused by the loss of cellular
material. Importantly, there was no change in the
biomechanical properties of the human aortas follow-
ing decellularisation, demonstrating that the process-
ing of the tissue preserved the structural integrity of
the extracellular matrix.
Decalcification and decellularisation of human
aorta therefore has the potential to retain the advan-
tages of the currently available cryopreserved human
Fig. 5 Collagen content of native and acellular human aorta.
a Collagen content and b denatured collagen content. Data
represents mean (n = 6) ± 95% confidence intervals. No
significant differences between the properties of acellular
arteries when compared to native controls as determined using
Students t-test
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arterial grafts while postponing or eliminating one of
the quintessential markers for deterioration: calcifica-
tion. Failure due to calcification is particularly trou-
blesome when allografts are used in younger patients,
and as such, an absence of calcium in the decellu-
larised arterial grafts has the potential to provide an
improved life-span and durability when compared to
the currently used cryopreserved allografts. Before
clinical use, however, it would be desirable to evaluate
the acellular aorta in a functional animal model to
determine patency.
Conclusions
The data presented indicates that decalcified decellu-
larised human aorta has the potential to be used as a
large diameter vascular graft. The process developed
was shown to be successful in removing both calcium
and cells from the aortic tissue, with greater than 94%
removal of total DNA. The decellularised aortas were
cytocompatible and the structure of the aortas were
maintained with no change to the biomechanical
properties.
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